Euroscreen and Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals partnered to discover and develop compounds against an undisclosed target to treat Type II diabetes and other diseases

Euroscreen S.A.

Belgium / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Johnson & Johnson

U.S. / Large-Cap Biopharma (>=$50 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced